Sheng Zhang
Impact in
- Infectious Diseases top 0.5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- SARS-CoV-2 detection and testing
- Otorhinolaryngology top 1%
- Head and Neck Cancer Studies
Papers in
- Oncology 66
- Cancer Immunotherapy and Biomarkers 16
- Colorectal Cancer Treatments and Studies 10
- HER2/EGFR in Cancer Research 6
Sheng Zhang
117 papers receiving 4.2k citations
Hit Papers
Peers
Comparison fields: 5 of 152
- Infectious Diseases 1.7k
- Otorhinolaryngology 402
- Neurology 735
- Modeling and Simulation 203
- Oncology 1.2k
Countries citing papers authored by Sheng Zhang
This map shows the geographic impact of Sheng Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheng Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheng Zhang more than expected).
Fields of papers citing papers by Sheng Zhang
This network shows the impact of papers produced by Sheng Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheng Zhang. The network helps show where Sheng Zhang may publish in the future.
Co-authors
The 25 scholars most cited alongside Sheng Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 4 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 3 | |
| 7 | 2023 | 1 | |
| 8 | 2022 | 13 | |
| 9 | 2022 | 4 | |
| 10 | 2022 | 12 | |
| 11 | 2021 | 8 | |
| 12 | 2020 | 34 | |
| 13 | 2020 | 20 | |
| 14 | 2020 | 10 | |
| 15 | 2017 | 18 | |
| 16 | 2016 | 3 | |
| 17 | 2016 | 19 | |
| 18 | 2014 | 18 | |
| 19 | 2011 | 6 | |
| 20 | 2007 | 2 |
About Sheng Zhang
Sheng Zhang is a scholar working on Oncology, Biological Psychiatry, Radiation, Pulmonary and Respiratory Medicine and Leadership and Management, having authored 121 papers that have together received 4.2k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (16 papers), SARS-CoV-2 and COVID-19 Research (12 papers), Colorectal Cancer Treatments and Studies (10 papers), COVID-19 Clinical Research Studies (9 papers), Advanced Radiotherapy Techniques (8 papers), Lung Cancer Treatments and Mutations (7 papers), HER2/EGFR in Cancer Research (6 papers) and SARS-CoV-2 detection and testing (6 papers). The work is most often cited by research in Infectious Diseases (1.7k citations), Otorhinolaryngology (402 citations), Neurology (735 citations), Modeling and Simulation (203 citations) and Oncology (1.2k citations). Sheng Zhang has collaborated with scholars based in China, United States and Russia. Frequent co-authors include Lingjun Ying, Kaijin Xu, Huaying Wang, Hongliu Cai, Xiaoxin Wu, Lanjuan Li, Xiaowei Xu, Jifang Sheng, Xiangao Jiang and Yunqing Qiu. Their work appears in journals such as Scientific Reports, Frontiers in Oncology, Oncotarget, Clinical Infectious Diseases and OncoTargets and Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.